학술논문
A functional inflammasome activation assay differentiates patients with pathogenic NLRP3 mutations and symptomatic patients with low penetrance variants
Document Type
Article
Author
Source
In Clinical Immunology March 2015 157(1):56-64
Subject
Language
ISSN
1521-6616